Clik here to view.
Ancestry.com launches DNA testing, gets $300M investment
updated The Generations Network, operator of Ancestry.com has just received $300 million from Spectrum Equity Investors, a Silicon Valley buyout firm, which will take a majority stake in the company....
View ArticleClik here to view.
Gene by Gene takes aim at 23andme with Arpeggi acquisition
Arpeggi, a startup formed by a group of entrepreneurs and scientists to accelerate research into the human genome, has been scooped by up Gene by Gene. The combined entity is positioned to be a major...
View ArticleClik here to view.
Genetics field opens up with California ruling that ‘natural phenomenon’...
In June of this year, the Supreme Court ruled that human genes should not be patented, a decision that is already having enormous impact on the future of science, technology, and medicine. This week, a...
View ArticleClik here to view.
Why the FDA is targeting Google-backed 23andMe: Unnecessary MRIs, mastectomies
FEATURE: Monday morning, federal regulators issued an enforcement action against 23andMe, a popular Silicon Valley-based genetic testing startup. Community forums and news sites across the Web exploded...
View ArticleClik here to view.
Genetics prof: Why I won’t waste my money on a DNA test in 2014
When a reporter for the New York Times set out to test three genetic tests, she received extremely varied results. The direct-to-consumer tests set back writer Kira Peikoff anywhere from $99 to $399....
View ArticleClik here to view.
Find out who made VentureBeat’s first ‘Naughty & Nice’ list
FEATURE: Although still a major global brand, the big guy in the red suit has a lot on his mind this year. Top of his worries: His old-school tracking and delivery system is ripe for disruption by some...
View ArticleLife sciences briefing: Monday, Oct. 22, 2007
Featured companies: Ablynx, Avant Immunotherapeutics, BioForm Medical, Celldex Therapeutics, Genomas, High-Throughput Genomics, Orchid Cellmark, ReliaGene Technologies, SarCode, TransMolecular, VisEn...
View ArticleDFJ funds new tech to push DNA testing closer to mass adoption
As the cost of DNA sequencing continues to fall, entrepreneurs and investors see an opportunity to bring bioinformatics tools to a mass market. “Innovations in DNA sequencing have led to an explosion...
View Article
